Doxazosin mesylate is an alpha-1 adrenergic antagonist belonging to the quinazoline class, widely prescribed for the management of hypertension and benign prostatic hyperplasia. To ensure the safety and… Read more











Doxazosin mesylate is an alpha-1 adrenergic antagonist belonging to the quinazoline class, widely prescribed for the management of hypertension and benign prostatic hyperplasia. To ensure the safety and efficacy of pharmaceutical formulations containing this active ingredient, laboratories rely on high-quality reference standards for rigorous analytical testing and quality control. This category includes the active pharmaceutical ingredient alongside its related compounds, such as pharmacopeial and non-pharmacopeial impurities, as well as stable isotope-labelled materials. These products are essential tools for pharmaceutical scientists engaged in impurity profiling, method validation, and the development of stability-indicating assays. By providing a comprehensive range of these materials, the catalogue supports precise quantitative analysis, enabling researchers to accurately identify and quantify degradation products and potential byproducts throughout the drug development and manufacturing lifecycle.